{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T09:31:16Z","timestamp":1759483876886,"version":"build-2065373602"},"reference-count":32,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1053\/j.ajkd.2017.06.013","type":"journal-article","created":{"date-parts":[[2017,8,9]],"date-time":"2017-08-09T02:15:50Z","timestamp":1502244950000},"page":"762-769","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Impact of Hyperuricemia on Long-term Outcomes of Kidney Transplantation: Analysis of the FAVORIT Study"],"prefix":"10.1053","volume":"70","author":[{"given":"Roberto S.","family":"Kalil","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myra A.","family":"Carpenter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anastasia","family":"Ivanova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Gravens-Mueller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alin A.","family":"John","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew R.","family":"Weir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Todd","family":"Pesavento","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew G.","family":"Bostom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc A.","family":"Pfeffer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence G.","family":"Hunsicker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1053\/j.ajkd.2017.06.013_bib1","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1046\/j.1523-1755.2000.00816.x","article-title":"Long-term survival in renal transplant recipients with graft function","volume":"57","author":"Ojo","year":"2000","journal-title":"Kidney Int"},{"issue":"2","key":"10.1053\/j.ajkd.2017.06.013_bib2","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2215\/CJN.05081107","article-title":"Management of cardiovascular disease in renal transplant recipients","volume":"3","author":"Shirali","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"issue":"10","key":"10.1053\/j.ajkd.2017.06.013_bib3","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1097\/01.tp.0000188722.84775.af","article-title":"New-onset gout after kidney transplantation: incidence, risk factors and implications","volume":"80","author":"Abbott","year":"2005","journal-title":"Transplantation"},{"issue":"5","key":"10.1053\/j.ajkd.2017.06.013_bib4","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1097\/TP.0b013e3181814f5b","article-title":"Hyperuricemia is associated with the development of the composite outcomes of new cardiovascular events and chronic allograft nephropathy","volume":"86","author":"Akalin","year":"2008","journal-title":"Transplantation"},{"issue":"18","key":"10.1053\/j.ajkd.2017.06.013_bib5","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1001\/jama.283.18.2404","article-title":"Serum uric acid level and cardiovascular mortality. The NHANES 1 epidemiologic follow-up study","volume":"283","author":"Fang","year":"2000","journal-title":"JAMA"},{"issue":"7","key":"10.1053\/j.ajkd.2017.06.013_bib6","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.amjcard.2008.11.042","article-title":"Association of uric acid with inflammation, progressive allograft dysfunction and post-transplant cardiovascular risk","volume":"103","author":"Bandukwala","year":"2009","journal-title":"Am J Cardiol"},{"issue":"5","key":"10.1053\/j.ajkd.2017.06.013_bib7","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/TP.0b013e3181c73c18","article-title":"The independent association between serum uric acid and graft outcome after kidney transplantation","volume":"89","author":"Haririan","year":"2010","journal-title":"Transplantation"},{"issue":"16","key":"10.1053\/j.ajkd.2017.06.013_bib8","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1161\/CIRCULATIONAHA.110.000588","article-title":"Homocysteine-lowering and cardiovascular disease outcomes in kidney transplant recipients: primary results from the Folic Acid for Vascular Outcome Reduction in Transplantation trial","volume":"123","author":"Bostom","year":"2011","journal-title":"Circulation"},{"issue":"1","key":"10.1053\/j.ajkd.2017.06.013_bib9","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1053\/j.ajkd.2008.08.010","article-title":"FAVORIT Study Investigators: Baseline characteristics of participants in the Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) Trial","volume":"53","author":"Bostom","year":"2009","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1053\/j.ajkd.2017.06.013_bib10","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","author":"Cockcroft","year":"1976","journal-title":"Nephron"},{"issue":"2","key":"10.1053\/j.ajkd.2017.06.013_bib11","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/clinchem\/26.2.227","article-title":"Use of 3,5-dichloro-2-hydroxibenzenesulforic acid\/4-aminophenazone chromogenic system in direct enzymic assay of uric acid in serum and urine","volume":"26","author":"Fossati","year":"1980","journal-title":"Clin Chem"},{"year":"1990","series-title":"Clinical Guide to Laboratory Tests","key":"10.1053\/j.ajkd.2017.06.013_bib12"},{"issue":"9","key":"10.1053\/j.ajkd.2017.06.013_bib13","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A\u00a0new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.ajkd.2017.06.013_bib14","unstructured":"Frank E, Harrell JR. Regression Modeling Strategies. R package version 5.1-0, 2017. https:\/\/CRAN.R-project.org\/package=rms. Accessed February 7, 2017."},{"issue":"9","key":"10.1053\/j.ajkd.2017.06.013_bib15","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1111\/j.1600-6143.2012.04101.x","article-title":"Kidney function and risk of cardiovascular disease and mortality in kidney transplant recipients: the FAVORIT trial","volume":"12","author":"Weiner","year":"2012","journal-title":"Am J Transplant"},{"issue":"7","key":"10.1053\/j.ajkd.2017.06.013_bib16","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1681\/ASN.2013040435","article-title":"BP, cardiovascular disease, and death in the Folic Acid for Vascular Outcome Reduction in\u00a0Transplantation trial","volume":"25","author":"Carpenter","year":"2014","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"17","key":"10.1053\/j.ajkd.2017.06.013_bib17","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMra0800885","article-title":"Uric acid and cardiovascular risk","volume":"359","author":"Feig","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"14","key":"10.1053\/j.ajkd.2017.06.013_bib18","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1001\/archinte.164.14.1546","article-title":"Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study","volume":"164","author":"Niskanen","year":"2004","journal-title":"Arch Intern Med"},{"issue":"6","key":"10.1053\/j.ajkd.2017.06.013_bib19","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1161\/01.STR.0000221716.55088.d4","article-title":"Uric acid is a risk factor for myocardial infarction and stroke: the Rotterdam study","volume":"37","author":"Bos","year":"2006","journal-title":"Stroke"},{"issue":"1","key":"10.1053\/j.ajkd.2017.06.013_bib20","doi-asserted-by":"crossref","first-page":"7","DOI":"10.7326\/0003-4819-131-1-199907060-00003","article-title":"Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study","volume":"131","author":"Culleton","year":"1999","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1053\/j.ajkd.2017.06.013_bib21","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S1047-2797(99)00037-X","article-title":"Serum uric acid and risk of coronary heart disease: Atherosclerosis Risk in Communities (ARIC) Study","volume":"10","author":"Moriarity","year":"2000","journal-title":"Ann Epidemiol"},{"issue":"8","key":"10.1053\/j.ajkd.2017.06.013_bib22","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1016\/j.transproceed.2009.07.080","article-title":"Hyperuricemia is a mediator of endothelial dysfunction and inflammation in renal allograft recipients","volume":"41","author":"Karbowska","year":"2009","journal-title":"Transplant Proc"},{"issue":"3","key":"10.1053\/j.ajkd.2017.06.013_bib23","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1161\/01.CIR.0000046448.26751.58","article-title":"Xanthine oxidase inhibition reverses endothelial dysfunction in heavy smokers","volume":"107","author":"Guthikonda","year":"2003","journal-title":"Circulation"},{"issue":"23","key":"10.1053\/j.ajkd.2017.06.013_bib24","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1161\/CIRCULATIONAHA.106.651117","article-title":"High dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid","volume":"114","author":"George","year":"2006","journal-title":"Circulation"},{"issue":"8","key":"10.1053\/j.ajkd.2017.06.013_bib25","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1001\/jama.300.8.924","article-title":"Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial","volume":"300","author":"Feig","year":"2008","journal-title":"JAMA"},{"issue":"5","key":"10.1053\/j.ajkd.2017.06.013_bib26","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1161\/HYPERTENSIONAHA.114.03953","article-title":"Allopurinol initiation and change in blood pressure in older adults with hypertension","volume":"64","author":"Beattie","year":"2014","journal-title":"Hypertension"},{"issue":"24","key":"10.1053\/j.ajkd.2017.06.013_bib27","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/j.jacc.2013.07.074","article-title":"Allopurinol reduces left ventricular mass in patients with type 2 diabetes and left ventricular hypertrophy","volume":"62","author":"Szwejkowski","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"7","key":"10.1053\/j.ajkd.2017.06.013_bib28","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1681\/ASN.2010111185","article-title":"Allopurinol reduces both left ventricular hypertrophy and endothelial dysfunction in patients with chronic kidney disease","volume":"22","author":"Kao","year":"2011","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"8","key":"10.1053\/j.ajkd.2017.06.013_bib29","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.2215\/CJN.01580210","article-title":"Effect of allopurinol in chronic kidney disease progression and cardiovascular risk","volume":"5","author":"Goicoechea","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"f4262","key":"10.1053\/j.ajkd.2017.06.013_bib30","article-title":"Association of plasma uric acid with ischaemic heart diseae and blood pressure: mendelian randomisation analysis of two large cohorts","volume":"347","author":"Palmer","year":"2013","journal-title":"BMJ"},{"issue":"10","key":"10.1053\/j.ajkd.2017.06.013_bib31","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.2215\/CJN.02700409","article-title":"Uric acid levels have no significant effect on renal function in adult renal transplant recipients: evidence from the Symphony Study","volume":"4","author":"Meier-Kriesche","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.ajkd.2017.06.013_bib32","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/ajt.13000","article-title":"Uric acid and the risk of graft failure in kidney transplant recipients: a re-assessment","volume":"15","author":"Kim","year":"2015","journal-title":"Am J Transplant"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638617308016?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638617308016?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T02:58:59Z","timestamp":1759460339000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638617308016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S0272638617308016"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2017.06.013","relation":{},"ISSN":["0272-6386"],"issn-type":[{"type":"print","value":"0272-6386"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of Hyperuricemia on Long-term Outcomes of Kidney Transplantation: Analysis of the FAVORIT Study","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2017.06.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by the National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}